EU Set to Debate ‘One Substance, One Assessment’ Chemicals Package to Overhaul Safety Rules
MEPs to debate 'one substance, one assessment' rule to simplify EU chemical safety laws. Industry must prepare for regulatory change.
The European Commission, under its regulatory framework concerning the Registration, Evaluation, Authorisation, and Restriction of Chemicals (REACH), has authorised the continued use of chromium trioxide, a substance listed in Annex XIV to Regulation (EC) No 1907/2006. This decision, documented as C(2023) 7832, was announced on November 22, 2023, and holds considerable relevance for stakeholders in the chemical industry.
Key Details of the Authorisation
- Substance: Chromium trioxide (EC No. 215-607-8, CAS No. 1333-82-0)
- Authorisation Holder: Schell GmbH & Co. KG Armaturentechnologie, Raiffeisenstrasse 31, 57462, Olpe, Germany
- Authorisation Number: REACH/23/24/0
- Authorised Use: Functional chrome plating with decorative character for sanitary applications
- Expiry of Review Period: 31 December 2028
The Commission's decision stems from Article 60(4) of Regulation (EC) No 1907/2006. The authorisation was granted on the basis that the socio-economic benefits of using chromium trioxide in this context significantly outweigh the risks posed to human health and the environment. Moreover, the Commission noted the lack of suitable alternative substances or technologies for this specific application.
Implications for Stakeholders
This decision marks a crucial point for companies like Schell GmbH & Co. KG, which specialises in decorative chrome plating. They can continue utilising chromium trioxide under specified conditions, ensuring compliance with REACH regulations. However, it is vital for these stakeholders to continually assess and mitigate risks associated with the use of this substance and explore potential alternatives for the future.
The Road Ahead
While the authorisation provides a temporary solution, it is accompanied by a review period deadline of December 31, 2028. This timeline necessitates ongoing research and development in finding safer, more sustainable alternatives. Companies utilising chromium trioxide should proactively engage in this research to stay ahead of regulatory changes and maintain their commitment to environmental and health standards.
Access the original source
Foresight continuously tracks 1000s of sources and maps updates to your portfolio:
- Get alerted when changes affect your products or operations
- Access source documents with full citations
- Collaborate with your team on alerts and decisions
Related Articles
EU Set to Debate ‘One Substance, One Assessment’ Chemicals Package to Overhaul Safety Rules
EU Plans Chemicals Regulation Overhaul in 2025 to Reduce Compliance Burdens
EU Chemical Regulatory Review: No Immediate Risk Actions for Aliphatic Dicarboxylic Acids (C3-C8)
EU Plans Chemicals Regulation Overhaul in 2025 to Reduce Compliance Burdens
The EU’s 2025 Work Programme will introduce a chemicals industry package in Q4 2025, aiming to simplify compliance, reduce administrative burdens, and enhance digital reporting.
EU Chemical Regulatory Review: No Immediate Risk Actions for Aliphatic Dicarboxylic Acids (C3-C8)
Assessment finds no immediate need for EU-wide regulatory actions, except for maleic acid’s skin sensitisation risks.
